Problems with Evidence Assessment in COVID-19 Health Policy Impact Evaluation (PEACHPIE): A systematic strength of methods review
View ORCID ProfileNoah A. Haber, Emma Clarke-Deelder, Avi Feller, Emily R. Smith, Joshua Salomon, Benjamin MacCormack-Gelles, Elizabeth M. Stone, Clara Bolster-Foucault, Jamie R. Daw, Laura A. Hatfield, Carrie E. Fry, Christopher B. Boyer, Eli Ben-Michael, Caroline M. Joyce, Beth S. Linas, Ian Schmid, Eric H. Au, Sarah E. Wieten, Brooke A Jarrett, Cathrine Axfors, Van Thu Nguyen, Beth Ann Griffin, Alyssa Bilinski, Elizabeth A. Stuart
doi: https://doi.org/10.1101/2021.01.21.21250243
Noah A. Haber
1Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA
ScDEmma Clarke-Deelder
2Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, MA, USA
MPhilAvi Feller
3Goldman School of Public Policy, UC Berkeley, Berkeley, CA, USA
PhDEmily R. Smith
4Department of Global Health, Milken Institute School of Public Health, George Washington University, Washington, D.C, USA
ScDJoshua Salomon
5Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA
PhDBenjamin MacCormack-Gelles
2Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, MA, USA
MSElizabeth M. Stone
6Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
MSClara Bolster-Foucault
7Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada
MScPHJamie R. Daw
8Health Policy and Management, Columbia University Mailman School of Public Health, New York, NY, USA
PhDLaura A. Hatfield
9Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
PhDCarrie E. Fry
10Department of Health Policy, Vanderbilt University, Nashville, TN, USA
PhDChristopher B. Boyer
11Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
MPHEli Ben-Michael
12Department of Statistics, UC Berkeley, Berkeley, CA, USA
PhDCaroline M. Joyce
7Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada
MPHBeth S. Linas
13Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
14Clinical Quality and Informatics, MITRE Corp, McLean, VA, USA
PhD, MHSIan Schmid
15Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
ScMEric H. Au
16School of Public Health, University of Sydney, Sydney, Australia
MPHSarah E. Wieten
1Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA
PhDBrooke A Jarrett
13Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
MSPHCathrine Axfors
1Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA
MD, PhDVan Thu Nguyen
1Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA
PhDBeth Ann Griffin
17RAND Corporation, Arlington, VA, USA
PhDAlyssa Bilinski
18Interfaculty Initiative in Health Policy, Harvard Graduate School of Arts and Sciences, Cambridge, MA, USA
MSElizabeth A. Stuart
15Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
PhDData Availability
Data, code, the review tool, and the review guidance are stored and available here: https://osf.io/9xmke/files/
Posted January 24, 2021.
Problems with Evidence Assessment in COVID-19 Health Policy Impact Evaluation (PEACHPIE): A systematic strength of methods review
Noah A. Haber, Emma Clarke-Deelder, Avi Feller, Emily R. Smith, Joshua Salomon, Benjamin MacCormack-Gelles, Elizabeth M. Stone, Clara Bolster-Foucault, Jamie R. Daw, Laura A. Hatfield, Carrie E. Fry, Christopher B. Boyer, Eli Ben-Michael, Caroline M. Joyce, Beth S. Linas, Ian Schmid, Eric H. Au, Sarah E. Wieten, Brooke A Jarrett, Cathrine Axfors, Van Thu Nguyen, Beth Ann Griffin, Alyssa Bilinski, Elizabeth A. Stuart
medRxiv 2021.01.21.21250243; doi: https://doi.org/10.1101/2021.01.21.21250243
Problems with Evidence Assessment in COVID-19 Health Policy Impact Evaluation (PEACHPIE): A systematic strength of methods review
Noah A. Haber, Emma Clarke-Deelder, Avi Feller, Emily R. Smith, Joshua Salomon, Benjamin MacCormack-Gelles, Elizabeth M. Stone, Clara Bolster-Foucault, Jamie R. Daw, Laura A. Hatfield, Carrie E. Fry, Christopher B. Boyer, Eli Ben-Michael, Caroline M. Joyce, Beth S. Linas, Ian Schmid, Eric H. Au, Sarah E. Wieten, Brooke A Jarrett, Cathrine Axfors, Van Thu Nguyen, Beth Ann Griffin, Alyssa Bilinski, Elizabeth A. Stuart
medRxiv 2021.01.21.21250243; doi: https://doi.org/10.1101/2021.01.21.21250243
Subject Area
Subject Areas
- Addiction Medicine (396)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2911)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12687)
- Forensic Medicine (10)
- Gastroenterology (825)
- Genetic and Genomic Medicine (4546)
- Geriatric Medicine (413)
- Health Economics (723)
- Health Informatics (2901)
- Health Policy (1067)
- Hematology (383)
- HIV/AIDS (920)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4313)
- Nursing (233)
- Nutrition (633)
- Oncology (2253)
- Ophthalmology (641)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (277)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1193)
- Primary Care Research (492)
- Public and Global Health (6901)
- Radiology and Imaging (1519)
- Respiratory Medicine (913)
- Rheumatology (435)
- Sports Medicine (381)
- Surgery (483)
- Toxicology (60)
- Transplantation (209)
- Urology (178)